Key TakeawaysBipartisan sponsors target “Big Medicine” conglomerates by separating insurers/PBMs from medical providers to reduce self-dealing, steerage, and price-setting conflicts across the care continuum.Market concentration is cited as severe: three PBMs process ~80% of prescription claims, and three wholesalers control ~98% of distribution, limiting competition and bargaining transparency.Independent pharmacy viability is positioned as a key […]
